Fundraising Fox

Qubit Pharmaceuticals

Paris, FR · Founded 2020 · 57 employees on LinkedIn · 3 known investors

Qubit Pharmaceuticals develops novel drug candidates using quantum physics, AI, and computational chemistry through its ATLAS platform for high-precision molecular simulation, modeling, and molecule generation. Its pipeline focuses on oncology, inflammation, and antiviral/pandemic-response programs, with fully owned and partnered drug discovery projects.

AI & Machine LearningBiotechQuantum Computing

Founders & leadership

RMRobert Marino
Robert MarinoinCEO

Investors · 3

QuantonationParis
XAngeParis · $1.1M – $10.8M
Omnes CapitalreportedParis

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Qubit Pharmaceuticals, a quantum physics-based drug discovery company, raises €16M - Omnes Capitalomnescapital.com · Jun 2022Qubit Pharmaceuticals Raises €16M in Funding - FinSMEsfinsmes.com · Jun 2022Qubit Pharmaceuticals raises 16 Meur seed round for quantum-based drug discovery • Quantonationquantonation.com · Jun 2022Qubit Pharmaceuticals Raises €16.1 Million in Seed Roundthequantuminsider.com · Jun 2022Qubit Pharmaceuticals | Sorbonne Université| Sorbonne universitésorbonne-universite.fr

Frequently asked questions

What does Qubit Pharmaceuticals do?
Qubit Pharmaceuticals develops novel drug candidates using quantum physics, AI, and computational chemistry through its ATLAS platform for high-precision molecular simulation, modeling, and molecule generation. Its pipeline focuses on oncology, inflammation, and antiviral/pandemic-response programs, with fully owned and partnered drug discovery projects.
Who are Qubit Pharmaceuticals's investors?
Qubit Pharmaceuticals's investors include Quantonation, XAnge, Omnes Capital.
Where is Qubit Pharmaceuticals headquartered?
Qubit Pharmaceuticals is headquartered in Paris, FR.